Abstract 2113P
Background
Cisplatin-induced nephrotoxicity (CIN) is a frequent dose-limiting adverse effect, and many nephroprotective strategies have been proposed to prevent its occurrence. Although multiple studies support premedication with magnesium (Mg) and hydration, this intervention has not been widely implemented, as some centers still replace it only after the occurrence of hypomagnesemia. We performed a systematic review and meta-analysis to evaluate the efficacy and effectiveness of Mg supplementation (suppl) prior to cisplatin.
Methods
We systematically searched Pubmed, Embase, and Cochrane databases for randomized clinical trials (RCT) and observational studies assessing prophylactic Mg suppl compared with placebo for patients receiving cisplatin-based chemotherapy. Primary outcomes were acute nephrotoxicity and hypomagnesemia events; secondary outcome included the association of CIN with variations on serum creatinine levels (ΔSCr). We used RevMan 5.1.7 and RStudio for statistical analysis; random-effects models to pool studies; and I2 statistics to assess heterogeneity.
Results
We included 24 studies with 3,803 patients. Nine were RCT and 15 observational cohort studies. We found a significant reduction of risk of CIN (all grades) in patients treated with prophylactic Mg compared to placebo (OR = 0.16; 95%CI 0.11 – 0.24; p<0.001). The pooled analysis including only studies adjusted for confounding variables demonstrated a 67% risk reduction of CIN with Mg suppl (p<0.0001). Mg prophylaxis was effective in both the clinical trial setting (OR = 0.22) and in the real-world data analysis (OR = 0.15). The benefit was seen across all tumor types and combinations of cisplatin-based chemotherapies included in the study. Hypomagnesemia events were significantly less frequent in the intervention group (OR = 0.27; 95%CI 0.16–0.45; p<0.000001). There was no difference regarding doses of Mg administered, and the ΔSCr were not significantly associated with the risk of CIN.
Conclusions
In patients undergoing cisplatin-based chemotherapy, prophylactic Mg suppl significantly reduces the risk of CIN and hypomagnesemia as compared with no prophylaxis.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2055P - Multidisciplinary Tumor-ICU Board: Enhancing care for critically Ill patients with solid tumors in the ICU
Presenter: Francisco Javier Ros Montana
Session: Poster session 06
2056P - Hospitalization, reconsultations and mortality in the field of oncological emergencies: Who is at higher risk?
Presenter: Eugenia María Martínez Madrid
Session: Poster session 06
2057P - Prevalence of frailty in long-term prostate cancer survivors after radical prostatectomy and its association with quality of life and emotional health
Presenter: Valentin Meissner
Session: Poster session 06
2058P - Reducing waste to improve sustainability and affordability of cancer treatment: Redispensing unused oral anticancer drugs
Presenter: Lisa-Marie Smale
Session: Poster session 06
2059P - The impact of a dental oncology clinic for patients (pts) prescribed bone-modifying agents (BMA) in a cancer centre
Presenter: Harriet Byrne
Session: Poster session 06
2060P - Prevalence and predictor of poor mental adjustment to cancer before lung cancer surgery
Presenter: Junhee Park
Session: Poster session 06
2061P - Network analysis of comprehensive concerns in patients with cancer: Differences between the sexes
Presenter: Kazumasa Yamamoto
Session: Poster session 06
2062P - The psychological distress (PsyD) evaluation in pancreatic cancer (PC) patients (pts): A mono-institutional analysis
Presenter: Maria Bensi
Session: Poster session 06
2063P - Lifestyle changes as cancer treatment: It is time to get specific with our patients
Presenter: Ana Isabel Martin Quesada
Session: Poster session 06
2064P - Hospitalisation of patients with cancer: Identifying points for improvement in patient care in a university hospital in Spain
Presenter: Silvia Roa
Session: Poster session 06